Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Croda International Pic has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are assigned to 2 distinct examiners and 2 distinct art units. This distribution indicates that each of the 2 pending office actions is being processed independently by different technical experts in separate administrative groups.
PHAN, DOAN THI-THUC is the busiest examiner, with 1 pending office action. With 2 distinct examiners handling 2 pending actions, there is no concentration of work under a single official. This requires the company to navigate the specific standards of two different art units simultaneously. The presence of 2 pending office actions across 2 distinct art units suggests that the company technical focus is split between different specialized areas of biotechnology. Practitioners must adapt to the varying examination cultures of these two separate divisions to advance the applications.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PHAN, DOAN THI-THUC | 1 | 42.8% | +47.6% |
| JOSEPH, JANET | 1 | 40.0% | +51.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18837120 | AGROCHEMICAL ADJUVANTS | PHAN, DOAN THI-THUC | — |
| 18708232 | SUSPENSION CONCENTRATE DISPERSANTS | JOSEPH, JANET | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18837120 | AGROCHEMICAL ADJUVANTS | PHAN, DOAN THI-THUC | 1613 | §112DP | Non-Final OA | — | Pending | Aug 08, 2024 |
| 18708232 | SUSPENSION CONCENTRATE DISPERSANTS | JOSEPH, JANET | 1611 | §103§112DP | Non-Final OA | — | Pending | May 08, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCroda International Pic has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Doan Thi-Thuc Phan has the most, with 1 of Croda International Pic's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
